Consensus is lacking on the use of oral supplements and systemic treatments for skin aging and photoaging
Our peptide injections guide provides detailed technique instructions applicable to IGF-1 LR3 and other subcutaneous peptides
In September 2023, FDA placed "Thymosin Beta-4, Fragment (LKKTETQ)," the substance sold as TB-500, on Category 2 of its interim 503A bulk drug substances list, meaning FDA identified significant safety concerns and would not permit licensed compounding pharmacies to use it
Similarly, each cell is also exposed to oxidative damage caused by outside chemicals and toxins
Its antioxidant properties target free radicals and toxins, neutralizing them to protect your cells and promote a healthier body
10.1096/fj.14-250050 FASEB J